Back
MoonLake Immunotherapeutics Stock Price Chart
Sponsored
MLTX
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
83
MLTX
MoonLake Immunotherapeutics
Last Price:
53.83
Seasonality Move:
10.4%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight selling pressure.
MoonLake Immunotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.49 | Buy |
20-day SMA: | 48.24 | Buy |
50-day SMA: | 46.5 | Buy |
200-day SMA: | 48.46 | Buy |
8-day EMA: | 50.08 | Buy |
20-day EMA: | 48.49 | Buy |
50-day EMA: | 46.7 | Buy |
200-day EMA: | 45.76 | Buy |
MoonLake Immunotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.36 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -49117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.38 - 50.14) | Buy |
Bollinger Bands (100): | (40.67 - 47.33) | Buy |
MoonLake Immunotherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 53.02 while MLTX 8-day simple moving average is 49.49, which is a Buy signal.
- The stock price of MLTX is 53.02 while MoonLake Immunotherapeutics 20-day SMA is 48.24, which makes it a Buy.
- MoonLake Immunotherapeutics 50-day simple moving average is 46.50 while MLTX share price is 53.02, making it a Buy technically.
- MLTX stock price is 53.02 and MoonLake Immunotherapeutics 200-day simple moving average is 48.46, creating a Buy signal.
MLTX Technical Analysis vs Fundamental Analysis
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Buy
The current MoonLake Immunotherapeutics [MLTX] share price is $53.02. The Score for MLTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
3.33B
Price in USD:
53.02
Share Volume:
663.08K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
35.11
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?
The MoonLake Immunotherapeutics stock price is 53.02 USD today. -
Will MLTX stock go up or go down?
MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is MoonLake Immunotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is not overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 53.02 while MLTX 8-day exponential moving average is 50.08, which is a Buy signal.
- The stock price of MLTX is 53.02 while MoonLake Immunotherapeutics 20-day EMA is 48.49, which makes it a Buy.
- MoonLake Immunotherapeutics 50-day exponential moving average is 46.70 while MLTX share price is 53.02, making it a Buy technically.
- MLTX stock price is 53.02 and MoonLake Immunotherapeutics 200-day simple moving average is 45.76, creating a Buy signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
- MLTX Moving Average Covergence Divergence (MACD) indicator is 1.36, suggesting MoonLake Immunotherapeutics is a Buy
- MoonLake Immunotherapeutics Relative Strength Index (RSI) is 67.83, which suggest MoonLake Immunotherapeutics is overbought
- The Bollinger Bands (25) for MoonLake Immunotherapeutics is (46.38 - 50.14), which suggest MoonLake Immunotherapeutics is a Buy
- The Bollinger Bands (100) for MoonLake Immunotherapeutics is (40.67 - 47.33), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.